Get More Information on Retinal Surgery Market - Request Sample Report
The Retinal Surgery Market Size was valued at USD 2.46 billion in 2023 and is expected to reach USD 4.16 billion by 2032 and grow at a CAGR of 6.05% over the forecast period of 2024 and 2032.
Retinal surgery devices are rapidly evolving to offer more effective treatments for a variety of retinal disorders. Minimally invasive surgical tools, for example, provide advantages such as less pain, minimal scarring, faster recovery times, and lower healthcare costs. The growth of the market is driven by increased awareness of eye health and improved access to advanced treatment options. As healthcare systems worldwide improve, access to retinal surgeries is expanding, leading to a growing demand for these devices.
These devices are primarily used to treat conditions like diabetic retinopathy, epiretinal membranes, retinal detachment, and macular holes. The market is also expanding due to an aging population that is more susceptible to eye problems and requires these treatments.
Diabetic retinopathy and retinal detachment are two significant eye conditions globally. As of 2023, diabetic retinopathy affects over 103 million people worldwide, a number that is expected to rise with increasing diabetes rates. In contrast, retinal detachment, while less common, impacts about 1 in 10,000 individuals annually. Both conditions play a major role in driving the demand for retinal surgical procedures, underscoring the critical need for innovative treatment solutions.
Drivers
Expanding healthcare facilities in emerging markets.
Rising awareness about eye health and the benefits of early diagnosis.
Rapid Innovations in retinal surgery devices, such as enhanced visualization systems, lasers, and micro-instruments.
Growing awareness of eye health and the advantages of early diagnosis is significantly influencing the retinal surgery market. As awareness of eye conditions such as diabetic retinopathy and macular degeneration increases, more individuals are recognizing the importance of regular eye checkups. Moreover, advancements in diagnostic technology facilitate quicker and more accurate identification of retinal disorders, which boosts the demand for surgical interventions. As individuals take a more proactive approach to managing their eye health, the frequency of routine screenings is expected to rise, further increasing the demand for retinal surgery devices.
Healthcare initiatives that emphasize the risks associated with untreated eye conditions are vital for raising public awareness. This focus on eye health is likely to result in more patients seeking treatment for retinal issues. The combination of heightened awareness and proactive healthcare practices is anticipated to drive growth in the retinal surgery market, making innovative treatment solutions essential to address the escalating demand.
Speedy innovations in retinal surgery devices are significantly advancing the field, with enhanced visualization systems, precision lasers, and refined micro-instruments leading the way. These technological advancements are improving surgical accuracy, making procedures less invasive, and enhancing patient outcomes. Surgeons now have better tools to address complex retinal conditions, reducing complications and recovery times. As these technologies continue to evolve, they are driving the growth and effectiveness of retinal surgery worldwide.
Restraints
The complications in retinal surgeries can discourage patients from choosing these procedures, impacting the overall demand for advanced surgical interventions.
A lack of trained ophthalmic surgeons can restrict market growth.
Expensive surgical devices and procedures, especially in developing regions, limit access to retinal surgeries.
In developing regions, retinal surgeries remain inaccessible owing to the high cost associated with surgical devices and procedures. The majority of low-and middle-income countries remain without access to advanced equipment, which means that the local healthcare facilities do not have the ability to provide the relevant treatment. Meanwhile, the absence of the necessary healthcare infrastructure combined with a shortage of trained healthcare professionals further creates a barrier towards timely and effective performance of these surgeries, which directly results in the preventable cases of people losing eyesight. Therefore, the major issue that needs to be focused on in order to address the given concern is the reduction of costs associated with surgical devices and the overall improvement of treatment affordability. Moreover, The challenge of high retinal surgery costs can be partially addressed by restricting foreign companies from importing their equipment until the local market is sufficiently saturated with similar domestic products. This approach could stimulate demand for local manufacturing and production, ultimately reducing costs and improving accessibility to essential treatments. Encouraging local production not only boosts the economy but also ensures that healthcare facilities can provide affordable solutions tailored to the needs of their communities. Additionally, the shortage of skilled ophthalmic surgeons hinders the growth of the retinal surgery market. Advanced procedures require specialized expertise that is not widely available, especially in developing regions. This lack of proficiency limits the number of surgeries that can be performed, constraining market expansion and leaving many patients without necessary eye care.
Additionally, the shortage of skilled ophthalmic surgeons hinders the growth of the retinal surgery market. Advanced procedures require specialized expertise that is not widely available, especially in developing regions. This lack of proficiency limits the number of surgeries that can be performed, constraining market expansion and leaving many patients without necessary eye care.
By Product
In 2023, vitrectomy packs segment dominated the market and represented more than 30% of the total share. These packs enhance surgical efficiency by combining all necessary instruments into a single, convenient package, which minimizes preparation time and improves operational workflow during procedures.
Meanwhile, the retinal laser equipment segment is expected to grow at a compound annual growth rate (CAGR) of 5.8% in the forthcoming years. This growth is driven by the equipment's precision, effectiveness, and versatility, enabling surgeons to target specific retinal areas with accuracy. This targeted approach reduces damage to surrounding tissues and results in improved treatment outcomes. Retinal laser devices have shown significant success in treating various conditions, including diabetic retinopathy, retinal tears, and macular degeneration.
By Application
In 2023, diabetic retinopathy captured the largest revenue share at 29.9%, reinforcing its role as a critical component of the market. This condition, recognized as a leading cause of blindness worldwide, arises from damage to the retina's blood vessels and can result in significant vision loss. The global increase in diabetes cases has heightened the urgency surrounding diabetic retinopathy in the field of ophthalmology. As a result, the rising demand for early detection and effective treatments using specialized surgical devices is a key driver of market growth.
Meanwhile, the Epiretinal Membrane (ERM) segment is expected to see the fastest compound annual growth rate (CAGR) of 6.3% during the forecast period. ERM develops when fibrous tissue forms on the retina's surface, leading to visual impairment. The increasing prevalence of age-related macular degeneration and diabetic retinopathy-both of which significantly contribute to ERM-plays a major role in driving the growth of this market segment.
By End-use
In 2023, the eye clinic segment emerged as the market leader, accounting for over 36.3% of total revenue, driven by factors such as cost-effectiveness, high patient volume, and specialized services. The rising public awareness of eye health significantly contributes to this growth. Ophthalmic clinics are increasingly recognized for their focus on eye care and the implementation of advanced technologies for targeted treatments of various retinal conditions. Concurrently, Ambulatory Surgery Centers (ASCs) are gaining popularity due to their efficiency and lower costs, offering outpatient surgical options.
Each segment plays a crucial role in providing retinal surgery services: hospitals lead in complexity and surgical volume, clinics focus on specialized care, and ASCs deliver high-quality yet affordable surgical solutions.
Hospital segment is projected to see substantial growth, with a compound annual growth rate (CAGR) expected to exceed 5.1% during the forecast period. This growth is largely attributed to the extensive infrastructure and specialized medical services available in hospitals, which support high adoption rates of retinal surgery devices. The consistent influx of patients, combined with advanced facilities and skilled specialists, results in a significant volume of retinal surgeries. Moreover, the increasing prevalence of eye disorders and the comprehensive care provided by hospitals further enhance the demand for retinal surgery devices in these settings.
In 2023, the North American market for retinal surgery devices held a substantial share of 36.7%. The region benefits from a highly skilled workforce of ophthalmologists and healthcare professionals specializing in retinal surgeries. These qualifications, along with the capability to use advanced surgical devices, contribute to a high adoption rate of these technologies in North America. Additionally, the prevalence of diabetic retinopathy is significant in this region and is expected to rise as diabetes cases increase.
In the Asia Pacific region, the retinal surgery devices market is projected to grow the fastest during the forecast period. This growth is driven by increased investments in healthcare infrastructure in emerging countries like China and India, making treatments more accessible and affordable. Japan is also anticipated to experience notable growth due to its aging population, which results in a higher incidence of age-related eye diseases. In 2023, the European retinal surgery devices market was recognized as promising due to its advanced healthcare infrastructure and professional ophthalmic care facilities throughout the region.
Need Any Customization Research On Retinal Surgery Market - Inquiry Now
The major key players are
Novartis - (Lucentis, Beovu)
Regeneron Pharmaceuticals - (Eylea, Dexamethasone Injectable)
Bausch + Lomb - (ILUVIEN, Retisert)
Alcon - (Vitrectomy Packs, Retina Laser System)
Zeiss - (VisuMax, CIRRUS HD-OCT)
Topcon - (3D OCT-1 Maestro, retinal laser systems)
Abbott Laboratories - (Sutureless Vitrectomy, Retinal Prosthesis System)
Hoya - (i-Trace, Retina Imaging Systems)
EyePoint Pharmaceuticals - (YUTIQ, DEXYCU)
NIDEK - (Laser Systems, OCT Systems)
Optos -(Ultra-widefield Imaging, Optomap)
Friedrich Miescher Institute - (Imaging and diagnostic solutions, clinical trials)
Carl Zeiss AG - (OCT imaging devices, surgical microscopes)
Lumenis - (SLT Laser Systems, photocoagulation lasers)
Katalyst Surgical - (Retinal surgical instruments, custom surgical packs)
Merck - (Ocular drug delivery systems, clinical trials)
Santen Pharmaceutical - (Ophthalmic solutions, surgical devices)
Vysion Technologies - (Ophthalmic imaging software, diagnostic tools)
DGH Technology - (Ultrasound systems, diagnostic devices)
IRIDEX Corporation - (MicroPulse laser systems, ophthalmic lasers)
In July 2024, Alcon Inc. announced its acquisition of Belkin Vision to enhance its glaucoma portfolio with the addition of direct selective laser trabeculoplasty (SLT).
In April 2024, Carl Zeiss Meditec AG announced that it completed the acquisition of the Dutch ophthalmic research center.
Report Attributes | Details |
---|---|
Market Size in 2023 | USD 2.46 Billion |
Market Size by 2032 | USD 4.16 Billion |
CAGR | CAGR of 6.05% From 2024 to 2032 |
Base Year | 2023 |
Forecast Period | 2024-2032 |
Historical Data | 2020-2022 |
Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
Key Segments | • By Product (Vitrectomy Machines and Retinal Laser Equipment) • By Application (Diabetic Retinopathy, Retinal Detachment and Other) • By End-Use (Hospitals, Ophthalmology Clinics and Others) |
Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe [Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
Company Profiles | Novartis, Regeneron Pharmaceuticals, Bausch + Lomb, Alcon, Zeiss, Topcon, Abbott Laboratories, Hoya, EyePoint Pharmaceuticals,NIDEK |
Key Drivers | • Rising awareness about eye health and the benefits of early diagnosis. • Rapid Innovations in retinal surgery devices, such as enhanced visualization systems, lasers, and micro-instruments. |
RESTRAINTS | • The complications in retinal surgeries can discourage patients from choosing these procedures, impacting the overall demand for advanced surgical interventions. • A lack of trained ophthalmic surgeons can restrict market growth. |
Ans- Retinal Surgery Market was valued at USD 2.46 billion in 2023 and is expected to reach USD 4.16 billion by 2032 and grow at a CAGR of 6.05% over the forecast period of 2024 and 2032.
Ans- the CAGR of Retinal Surgery Market during the forecast period is of 6.05% from 2024-2032.
Ans- In 2023, North America led the Retinal Surgery Market, capturing a significant revenue share of 36.7%.
Ans- one main growth factor for the Retinal Surgery Market is
Ans- challenges in Retinal Surgery Market are
Table of Content
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2023)
5.2 Prescription Trends, (2023), by Region
5.3 Device Volume, by Region (2020-2032)
5.4 Healthcare Spending, by Region, (Government, Commercial, Private, Out-of-Pocket), 2023
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and supply chain strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Retinal Surgery Devices Market Segmentation, Product
7.1 Chapter Overview
7.2 Vitrectomy Machines
7.2.1 Vitrectomy Machines Market Trends Analysis (2020-2032)
7.2.2 Vitrectomy Machines Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Retinal Laser Equipment
7.3.1 Retinal Laser Equipment Market Trends Analysis (2020-2032)
7.3.2 Retinal Laser Equipment Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Retinal Surgery Devices Market Segmentation, by Application
8.1 Chapter Overview
8.2 Diabetic Retinopathy
8.2.1 Diabetic Retinopathy Market Trends Analysis (2020-2032)
8.2.2 Diabetic Retinopathy Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Retinal Detachment
8.3.1 Retinal Detachment Market Trends Analysis (2020-2032)
8.3.2 Retinal Detachment Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Other
8.4.1 Other Market Trends Analysis (2020-2032)
8.4.2 Other Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Retinal Surgery Devices Market Segmentation, by End User
9.1 Chapter Overview
9.2 Hospitals
9.2.1 Hospitals Market Trends Analysis (2020-2032)
9.2.2 Hospitals Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Ophthalmology Clinics
9.3.1 Ophthalmology Clinics Market Trends Analysis (2020-2032)
9.3.2 Ophthalmology Clinics Market Size Estimates and Forecasts to 2032 (USD Billion)
9.4 Others
9.4.1 Others Market Trends Analysis (2020-2032)
9.4.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America Retinal Surgery Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.2.3 North America Retinal Surgery Devices Market Estimates and Forecasts, Product (2020-2032) (USD Billion)
10.2.4 North America Retinal Surgery Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.5 North America Retinal Surgery Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.2.6 USA
10.2.6.1 USA Retinal Surgery Devices Market Estimates and Forecasts, Product (2020-2032) (USD Billion)
10.2.6.2 USA Retinal Surgery Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.6.3 USA Retinal Surgery Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.2.7 Canada
10.2.7.1 Canada Retinal Surgery Devices Market Estimates and Forecasts, Product (2020-2032) (USD Billion)
10.2.7.2 Canada Retinal Surgery Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.7.3 Canada Retinal Surgery Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.2.8 Mexico
10.2.8.1 Mexico Retinal Surgery Devices Market Estimates and Forecasts, Product (2020-2032) (USD Billion)
10.2.8.2 Mexico Retinal Surgery Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.8.3 Mexico Retinal Surgery Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Trends Analysis
10.3.1.2 Eastern Europe Retinal Surgery Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.1.3 Eastern Europe Retinal Surgery Devices Market Estimates and Forecasts, Product (2020-2032) (USD Billion)
10.3.1.4 Eastern Europe Retinal Surgery Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.5 Eastern Europe Retinal Surgery Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.1.6 Poland
10.3.1.6.1 Poland Retinal Surgery Devices Market Estimates and Forecasts, Product (2020-2032) (USD Billion)
10.3.1.6.2 Poland Retinal Surgery Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.6.3 Poland Retinal Surgery Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.1.7 Romania
10.3.1.7.1 Romania Retinal Surgery Devices Market Estimates and Forecasts, Product (2020-2032) (USD Billion)
10.3.1.7.2 Romania Retinal Surgery Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.7.3 Romania Retinal Surgery Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.1.8 Hungary
10.3.1.8.1 Hungary Retinal Surgery Devices Market Estimates and Forecasts, Product (2020-2032) (USD Billion)
10.3.1.8.2 Hungary Retinal Surgery Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.8.3 Hungary Retinal Surgery Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.1.9 Turkey
10.3.1.9.1 Turkey Retinal Surgery Devices Market Estimates and Forecasts, Product (2020-2032) (USD Billion)
10.3.1.9.2 Turkey Retinal Surgery Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.9.3 Turkey Retinal Surgery Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.1.10 Rest of Eastern Europe
10.3.1.10.1 Rest of Eastern Europe Retinal Surgery Devices Market Estimates and Forecasts, Product (2020-2032) (USD Billion)
10.3.1.10.2 Rest of Eastern Europe Retinal Surgery Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.10.3 Rest of Eastern Europe Retinal Surgery Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2 Western Europe
10.3.2.1 Trends Analysis
10.3.2.2 Western Europe Retinal Surgery Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.2.3 Western Europe Retinal Surgery Devices Market Estimates and Forecasts, Product (2020-2032) (USD Billion)
10.3.2.4 Western Europe Retinal Surgery Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.5 Western Europe Retinal Surgery Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.6 Germany
10.3.2.6.1 Germany Retinal Surgery Devices Market Estimates and Forecasts, Product (2020-2032) (USD Billion)
10.3.2.6.2 Germany Retinal Surgery Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.6.3 Germany Retinal Surgery Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.7 France
10.3.2.7.1 France Retinal Surgery Devices Market Estimates and Forecasts, Product (2020-2032) (USD Billion)
10.3.2.7.2 France Retinal Surgery Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.7.3 France Retinal Surgery Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.8 UK
10.3.2.8.1 UK Retinal Surgery Devices Market Estimates and Forecasts, Product (2020-2032) (USD Billion)
10.3.2.8.2 UK Retinal Surgery Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.8.3 UK Retinal Surgery Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.9 Italy
10.3.2.9.1 Italy Retinal Surgery Devices Market Estimates and Forecasts, Product (2020-2032) (USD Billion)
10.3.2.9.2 Italy Retinal Surgery Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.9.3 Italy Retinal Surgery Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.10 Spain
10.3.2.10.1 Spain Retinal Surgery Devices Market Estimates and Forecasts, Product (2020-2032) (USD Billion)
10.3.2.10.2 Spain Retinal Surgery Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.10.3 Spain Retinal Surgery Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.11 Netherlands
10.3.2.11.1 Netherlands Retinal Surgery Devices Market Estimates and Forecasts, Product (2020-2032) (USD Billion)
10.3.2.11.2 Netherlands Retinal Surgery Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.11.3 Netherlands Retinal Surgery Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.12 Switzerland
10.3.2.12.1 Switzerland Retinal Surgery Devices Market Estimates and Forecasts, Product (2020-2032) (USD Billion)
10.3.2.12.2 Switzerland Retinal Surgery Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.12.3 Switzerland Retinal Surgery Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.13 Austria
10.3.2.13.1 Austria Retinal Surgery Devices Market Estimates and Forecasts, Product (2020-2032) (USD Billion)
10.3.2.13.2 Austria Retinal Surgery Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.13.3 Austria Retinal Surgery Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.14 Rest of Western Europe
10.3.2.14.1 Rest of Western Europe Retinal Surgery Devices Market Estimates and Forecasts, Product (2020-2032) (USD Billion)
10.3.2.14.2 Rest of Western Europe Retinal Surgery Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.14.3 Rest of Western Europe Retinal Surgery Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4 Asia Pacific
10.4.1 Trends Analysis
10.4.2 Asia Pacific Retinal Surgery Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.4.3 Asia Pacific Retinal Surgery Devices Market Estimates and Forecasts, Product (2020-2032) (USD Billion)
10.4.4 Asia Pacific Retinal Surgery Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.5 Asia Pacific Retinal Surgery Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.6 China
10.4.6.1 China Retinal Surgery Devices Market Estimates and Forecasts, Product (2020-2032) (USD Billion)
10.4.6.2 China Retinal Surgery Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.6.3 China Retinal Surgery Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.7 India
10.4.7.1 India Retinal Surgery Devices Market Estimates and Forecasts, Product (2020-2032) (USD Billion)
10.4.7.2 India Retinal Surgery Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.7.3 India Retinal Surgery Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.8 Japan
10.4.8.1 Japan Retinal Surgery Devices Market Estimates and Forecasts, Product (2020-2032) (USD Billion)
10.4.8.2 Japan Retinal Surgery Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.8.3 Japan Retinal Surgery Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.9 South Korea
10.4.9.1 South Korea Retinal Surgery Devices Market Estimates and Forecasts, Product (2020-2032) (USD Billion)
10.4.9.2 South Korea Retinal Surgery Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.9.3 South Korea Retinal Surgery Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.10 Vietnam
10.4.10.1 Vietnam Retinal Surgery Devices Market Estimates and Forecasts, Product (2020-2032) (USD Billion)
10.4.10.2 Vietnam Retinal Surgery Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.10.3 Vietnam Retinal Surgery Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.11 Singapore
10.4.11.1 Singapore Retinal Surgery Devices Market Estimates and Forecasts, Product (2020-2032) (USD Billion)
10.4.11.2 Singapore Retinal Surgery Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.11.3 Singapore Retinal Surgery Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.12 Australia
10.4.12.1 Australia Retinal Surgery Devices Market Estimates and Forecasts, Product (2020-2032) (USD Billion)
10.4.12.2 Australia Retinal Surgery Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.12.3 Australia Retinal Surgery Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.13 Rest of Asia Pacific
10.4.13.1 Rest of Asia Pacific Retinal Surgery Devices Market Estimates and Forecasts, Product (2020-2032) (USD Billion)
10.4.13.2 Rest of Asia Pacific Retinal Surgery Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.13.3 Rest of Asia Pacific Retinal Surgery Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5 Middle East and Africa
10.5.1 Middle East
10.5.1.1 Trends Analysis
10.5.1.2 Middle East Retinal Surgery Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.1.3 Middle East Retinal Surgery Devices Market Estimates and Forecasts, Product (2020-2032) (USD Billion)
10.5.1.4 Middle East Retinal Surgery Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.5 Middle East Retinal Surgery Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.1.6 UAE
10.5.1.6.1 UAE Retinal Surgery Devices Market Estimates and Forecasts, Product (2020-2032) (USD Billion)
10.5.1.6.2 UAE Retinal Surgery Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.6.3 UAE Retinal Surgery Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.1.7 Egypt
10.5.1.7.1 Egypt Retinal Surgery Devices Market Estimates and Forecasts, Product (2020-2032) (USD Billion)
10.5.1.7.2 Egypt Retinal Surgery Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.7.3 Egypt Retinal Surgery Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.1.8 Saudi Arabia
10.5.1.8.1 Saudi Arabia Retinal Surgery Devices Market Estimates and Forecasts, Product (2020-2032) (USD Billion)
10.5.1.8.2 Saudi Arabia Retinal Surgery Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.8.3 Saudi Arabia Retinal Surgery Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.1.9 Qatar
10.5.1.9.1 Qatar Retinal Surgery Devices Market Estimates and Forecasts, Product (2020-2032) (USD Billion)
10.5.1.9.2 Qatar Retinal Surgery Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.9.3 Qatar Retinal Surgery Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.1.10 Rest of Middle East
10.5.1.10.1 Rest of Middle East Retinal Surgery Devices Market Estimates and Forecasts, Product (2020-2032) (USD Billion)
10.5.1.10.2 Rest of Middle East Retinal Surgery Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.10.3 Rest of Middle East Retinal Surgery Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.2 Africa
10.5.2.1 Trends Analysis
10.5.2.2 Africa Retinal Surgery Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.2.3 Africa Retinal Surgery Devices Market Estimates and Forecasts, Product (2020-2032) (USD Billion)
10.5.2.4 Africa Retinal Surgery Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.5 Africa Retinal Surgery Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.2.6 South Africa
10.5.2.6.1 South Africa Retinal Surgery Devices Market Estimates and Forecasts, Product (2020-2032) (USD Billion)
10.5.2.6.2 South Africa Retinal Surgery Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.6.3 South Africa Retinal Surgery Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.2.7 Nigeria
10.5.2.7.1 Nigeria Retinal Surgery Devices Market Estimates and Forecasts, Product (2020-2032) (USD Billion)
10.5.2.7.2 Nigeria Retinal Surgery Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.7.3 Nigeria Retinal Surgery Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.2.8 Rest of Africa
10.5.2.8.1 Rest of Africa Retinal Surgery Devices Market Estimates and Forecasts, Product (2020-2032) (USD Billion)
10.5.2.8.2 Rest of Africa Retinal Surgery Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.8.3 Rest of Africa Retinal Surgery Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America Retinal Surgery Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.6.3 Latin America Retinal Surgery Devices Market Estimates and Forecasts, Product (2020-2032) (USD Billion)
10.6.4 Latin America Retinal Surgery Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.5 Latin America Retinal Surgery Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.6.6 Brazil
10.6.6.1 Brazil Retinal Surgery Devices Market Estimates and Forecasts, Product (2020-2032) (USD Billion)
10.6.6.2 Brazil Retinal Surgery Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.6.3 Brazil Retinal Surgery Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.6.7 Argentina
10.6.7.1 Argentina Retinal Surgery Devices Market Estimates and Forecasts, Product (2020-2032) (USD Billion)
10.6.7.2 Argentina Retinal Surgery Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.7.3 Argentina Retinal Surgery Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.6.8 Colombia
10.6.8.1 Colombia Retinal Surgery Devices Market Estimates and Forecasts, Product (2020-2032) (USD Billion)
10.6.8.2 Colombia Retinal Surgery Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.8.3 Colombia Retinal Surgery Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.6.9 Rest of Latin America
10.6.9.1 Rest of Latin America Retinal Surgery Devices Market Estimates and Forecasts, Product (2020-2032) (USD Billion)
10.6.9.2 Rest of Latin America Retinal Surgery Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.9.3 Rest of Latin America Retinal Surgery Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11. Company Profiles
11.1 Bausch + Lomb Incorporated
11.1.1 Company Overview
11.1.2 Financial
11.1.3 Products/ Services Offered
11.1.4 SWOT Analysis
11.2 Novartis
11.2.1 Company Overview
11.2.2 Financial
11.2.3 Products/ Services Offered
11.2.4 SWOT Analysis
11.3 Regeneron Pharmaceuticals
11.3.1 Company Overview
11.3.2 Financial
11.3.3 Products/ Services Offered
11.3.4 SWOT Analysis
11.4 Alcon
11.4.1 Company Overview
11.4.2 Financial
11.4.3 Products/ Services Offered
11.4.4 SWOT Analysis
11.5 Zeiss
11.5.1 Company Overview
11.5.2 Financial
11.5.3 Products/ Services Offered
11.5.4 SWOT Analysis
11.6 Topcon
11.6.1 Company Overview
11.6.2 Financial
11.6.3 Products/ Services Offered
11.6.4 SWOT Analysis
11.7 Abbott Laboratories
11.7.1 Company Overview
11.7.2 Financial
11.7.3 Products/ Services Offered
11.7.4 SWOT Analysis
11.8 Hoya
11.8.1 Company Overview
11.8.2 Financial
11.8.3 Products/ Services Offered
11.8.4 SWOT Analysis
11.9 EyePoint Pharmaceuticals
11.9.1 Company Overview
11.9.2 Financial
11.9.3 Products/ Services Offered
11.9.4 SWOT Analysis
11.10 NIDEK
11.10.1 Company Overview
11.10.2 Financial
11.10.3 Products/ Services Offered
11.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments:
By Product
Vitrectomy Machines
Retinal Laser Equipment
By Application
Diabetic Retinopathy
Retinal Detachment
Other
By End-Use
Hospitals
Ophthalmology Clinics
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
REGIONAL COVERAGE:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Product Matrix which gives a detailed comparison of product portfolio of each company
Geographic Analysis
Additional countries in any of the regions
Company Information
Detailed analysis and profiling of additional market players (Up to five)
The Coronary Stent Market size was valued at USD 9.63 Billion In 2023 & is estimated to reach USD 12.89 Billion by 2032 and increase at a compound annual growth rate of 3.3% between 2024 and 2032.
The Spinal Muscular Atrophy Treatment Market size was estimated at USD 4.48 billion in 2023 and is expected to reach USD 8.16 billion by 2032 at a CAGR of 6.9% during the forecast period of 2024-2032.
The Operating Room Management Market Size was valued at USD 2.80 billion in 2023, and is expected to reach USD 7.06 billion by 2031 and grow at a CAGR of 12.24% over the forecast period 2024-2031.
The Hormonal Contraceptives Market size was valued at USD 17.58 Billion in 2023 and is expected to reach USD 25.39 Billion By 2031 with a growing CAGR of 4.70% over the forecast period of 2024-2031.
The Breast Implants Market Size was valued at USD 3.06 Billion in 2023, and is expected to reach USD 5.34 Billion by 2032, and grow at a CAGR of 6.67%.
The Nano Biotechnology Market Size was valued at USD 5.6 billion in 2023, and is expected to reach USD 12.67 billion by 2031 and grow at a CAGR of 9.5% over the forecast period 2024-2031.
Hi! Click one of our member below to chat on Phone